229 related articles for article (PubMed ID: 7636970)
1. Mapping of mutations contributing to the temperature sensitivity of the Sabin 1 vaccine strain of poliovirus.
Georgescu MM; Tardy-Panit M; Guillot S; Crainic R; Delpeyroux F
J Virol; 1995 Sep; 69(9):5278-86. PubMed ID: 7636970
[TBL] [Abstract][Full Text] [Related]
2. A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice.
Tardy-Panit M; Blondel B; Martin A; Tekaia F; Horaud F; Delpeyroux F
J Virol; 1993 Aug; 67(8):4630-8. PubMed ID: 8392604
[TBL] [Abstract][Full Text] [Related]
3. Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine.
Bouchard MJ; Lam DH; Racaniello VR
J Virol; 1995 Aug; 69(8):4972-8. PubMed ID: 7609067
[TBL] [Abstract][Full Text] [Related]
4. Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis.
Georgescu MM; Balanant J; Macadam A; Otelea D; Combiescu M; Combiescu AA; Crainic R; Delpeyroux F
J Virol; 1997 Oct; 71(10):7758-68. PubMed ID: 9311861
[TBL] [Abstract][Full Text] [Related]
5. Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature.
Christodoulou C; Colbere-Garapin F; Macadam A; Taffs LF; Marsden S; Minor P; Horaud F
J Virol; 1990 Oct; 64(10):4922-9. PubMed ID: 2168976
[TBL] [Abstract][Full Text] [Related]
6. An aspartic acid at amino acid 108 is required to rescue infectious virus after transfection of a poliovirus cDNA containing a CGDD but not SGDD amino acid motif in 3Dpol.
Walker DE; McPherson D; Jablonski SA; McPherson S; Morrow CD
J Virol; 1995 Dec; 69(12):8173-7. PubMed ID: 7494345
[TBL] [Abstract][Full Text] [Related]
7. Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus.
McGoldrick A; Macadam AJ; Dunn G; Rowe A; Burlison J; Minor PD; Meredith J; Evans DJ; Almond JW
J Virol; 1995 Dec; 69(12):7601-5. PubMed ID: 7494267
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of mouse-virulent poliovirus type 1 Mahoney mutants: involvement of residues of polypeptides VP1 and VP2 located on the inner surface of the capsid protein shell.
Couderc T; Hogle J; Le Blay H; Horaud F; Blondel B
J Virol; 1993 Jul; 67(7):3808-17. PubMed ID: 8389907
[TBL] [Abstract][Full Text] [Related]
9. In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain.
Kohara M; Omata T; Kameda A; Semler BL; Itoh H; Wimmer E; Nomoto A
J Virol; 1985 Mar; 53(3):786-92. PubMed ID: 2983090
[TBL] [Abstract][Full Text] [Related]
10. Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates.
Macadam AJ; Pollard SR; Ferguson G; Skuce R; Wood D; Almond JW; Minor PD
Virology; 1993 Jan; 192(1):18-26. PubMed ID: 8390752
[TBL] [Abstract][Full Text] [Related]
11. Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees.
Friedrich F
Acta Virol; 1996 Jun; 40(3):157-70. PubMed ID: 8891097
[TBL] [Abstract][Full Text] [Related]
12. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
[TBL] [Abstract][Full Text] [Related]
13. Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees.
Macadam AJ; Arnold C; Howlett J; John A; Marsden S; Taffs F; Reeve P; Hamada N; Wareham K; Almond J
Virology; 1989 Oct; 172(2):408-14. PubMed ID: 2552655
[TBL] [Abstract][Full Text] [Related]
14. Sabin type 2 polioviruses with intertypic vaccine/vaccine recombinant genomes.
Georgopoulou A; Markoulatos P
Eur J Clin Microbiol Infect Dis; 2001 Nov; 20(11):792-9. PubMed ID: 11783695
[TBL] [Abstract][Full Text] [Related]
15. Studies on the attenuation phenotype of polio vaccines: poliovirus RNA polymerase derived from Sabin type 1 sequence is temperature sensitive in the uridylylation of VPg.
Paul AV; Mugavero J; Yin J; Hobson S; Schultz S; van Boom JH; Wimmer E
Virology; 2000 Jun; 272(1):72-84. PubMed ID: 10873750
[TBL] [Abstract][Full Text] [Related]
16. Correlation of mutations and recombination with growth kinetics of poliovirus vaccine strains.
Pliaka V; Kyriakopoulou Z; Tsakogiannis D; Ruether IG; Gartzonika C; Levidiotou-Stefanou S; Krikelis A; Markoulatos P
Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1513-23. PubMed ID: 20820837
[TBL] [Abstract][Full Text] [Related]
17. Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis.
Furione M; Guillot S; Otelea D; Balanant J; Candrea A; Crainic R
Virology; 1993 Sep; 196(1):199-208. PubMed ID: 8102826
[TBL] [Abstract][Full Text] [Related]
18. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.
Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
J Virol; 1988 Aug; 62(8):2828-35. PubMed ID: 2839704
[TBL] [Abstract][Full Text] [Related]
19. Type 2 poliovirus recombinants isolated from vaccine-associated cases and from healthy contacts in Brazil.
Friedrich F; Da-Silva EF; Schatzmayr HG
Acta Virol; 1996 Feb; 40(1):27-33. PubMed ID: 8886095
[TBL] [Abstract][Full Text] [Related]
20. Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype.
Kawamura N; Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
J Virol; 1989 Mar; 63(3):1302-9. PubMed ID: 2536835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
